- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Drug Pipelines
- January 2019
- 40 Pages
Global
From €1448EUR$1,500USD£1,242GBP
From €2510EUR$2,600USD£2,153GBP
- Report
- May 2021
- 50 Pages
China
From €2510EUR$2,600USD£2,153GBP
- Report
- June 2022
- 65 Pages
Europe
From €1448EUR$1,500USD£1,242GBP
- Drug Pipelines
- March 2021
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- August 2023
- 74 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Drug Pipelines
- July 2020
- 62 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- March 2020
- 165 Pages
Global
From €5183EUR$5,370USD£4,446GBP
- Report
- June 2023
- 120 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Book
- April 2020
- 1328 Pages
- Book
- May 2015
- 368 Pages
- Book
- July 2024
- 352 Pages
The Sedation market within the context of Anesthetic Drugs is a subset of the larger anesthetic drug market. It is composed of drugs used to induce a state of sedation, which is a state of reduced consciousness and decreased responsiveness to external stimuli. Sedation is used in a variety of medical procedures, such as endoscopies, colonoscopies, and other minor surgeries. It is also used in intensive care units to reduce the stress of critically ill patients.
The sedation market is composed of a variety of drugs, including benzodiazepines, barbiturates, and propofol. These drugs are used to induce a state of sedation, as well as to reduce anxiety and pain. The sedation market is highly competitive, with a number of companies offering a variety of drugs.
Some of the companies in the sedation market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. These companies offer a variety of sedation drugs, including benzodiazepines, barbiturates, and propofol. Show Less Read more
